Unbiased AI-powered news
7 stories related to this topic, newest first.
foxbusiness.comPresident Donald Trump signed an executive order in April 2026 directing faster study of psychedelic compounds for conditions including PTSD and depression. The administration also issued priority review vouchers to three companies developing related therapies.
Washington ExaminerPresident Trump signed an executive order to expand research into psychedelic therapies. The order follows state-level actions in Texas and Mississippi on ibogaine access.
The HillThe Hill will host a policy forum on psychedelic medicines for mental health treatment. The event begins at 8:30 a.m. ET and will include lawmakers, researchers, and advocates.
realitytea.comPresident Trump signed an executive order last month directing faster research and increased federal funding for psychedelic drug therapies. Rep. Lou Correa (D-CA) said the measure could help veterans with PTSD or traumatic brain injuries as well as people facing other mental hea…
realitytea.comPresident Trump signed an executive order in April that accelerates research and increases funding for psychedelic drug therapies. A California congressman leading a bipartisan effort to advance the therapies discussed the initiative on CBS News. The discussion emphasized support…
New York PostThe Food and Drug Administration has greenlit the first human clinical trial of an ibogaine derivative in the United States to test its potential as a treatment for alcohol use disorder. This follows President Trump's executive order to fast-track psychedelic research. The agency…
Texas has allocated $50 million to study ibogaine for opioid addiction treatment, following legislative approval. The Trump administration recently issued an executive order to expedite psychedelic research, including ibogaine. Advocates, including former officials, are promoting…